Decoupled neoantigen cross-presentation in tumors with high intratumor heterogeneity reduces dendritic cell activation to limit anti-tumor immunity
K. B. Nguyen, C. J. Copeland, C. M. Backlund, N. G. Klop-Packel, T. Remba, B. Kim, N. K. Singh, M. E. Birnbaum, D. J. Irvine, S. Spranger
This study shows that clonal neoantigen expression enhances dendritic cell activation and anti-tumor immunity, while subclonal expression reduces it in tumors with high intratumor heterogeneity.
bioRxiv · Dec 16, 2022Immunology